GlobeNewswire Inc.··NaQuotient Therapeutics Lands $2.2B Merck Deal for IBD Drug Discovery Platform
Quotient Therapeutics and Merck partner on IBD drug discovery, with Quotient receiving $20M upfront and up to $2.2B in milestones.
MRKimmunologydrug discovery